Transendothelial migration (TEM) of in vitro generated dendritic cell vaccine in cancer immunotherapy
Many efforts have been made to improve the efficacy of dendritic cell (DC) vaccines in DC-based cancer immunotherapy. One of these efforts is to deliver a DC vaccine more efficiently to the regional lymph nodes (rLNs) to induce stronger anti-tumor immunity. Together with chemotaxis, transendothelial...
Saved in:
Published in | Archives of pharmacal research Vol. 42; no. 7; pp. 582 - 590 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Seoul
Pharmaceutical Society of Korea
01.07.2019
대한약학회 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Many efforts have been made to improve the efficacy of dendritic cell (DC) vaccines in DC-based cancer immunotherapy. One of these efforts is to deliver a DC vaccine more efficiently to the regional lymph nodes (rLNs) to induce stronger anti-tumor immunity. Together with chemotaxis, transendothelial migration (TEM) is believed to be a critical and indispensable step for DC vaccine migration to the rLNs after administration. However, the mechanism underlying the
in vitro
-generated DC TEM in DC-based cancer immunotherapy has been largely unknown. Currently, junctional adhesion molecules (JAMs) were found to play an important role in the TEM of
in vitro
generated DC vaccines. This paper reviews the TEM of DC vaccines and TEM-associated JAM molecules. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 http://link.springer.com/10.1007/s12272-019-01145-w |
ISSN: | 0253-6269 1976-3786 |
DOI: | 10.1007/s12272-019-01145-w |